All News

Company Statement: Teva Reaches Agreement with State of Oklahoma to Resolve State’s Claims Against the Company

Ref: Business Wire

Tags: Press Release Teva United States Corporate Affairs

Snakebite: WHO targets 50% reduction in deaths and disabilities

Ref: WHO

Tags: Press Release World WHO Medical Affairs

DBV Technologies Announces Results of its 2019 Ordinary and Extraordinary General Meeting and the Appointment of Viviane Monges to the Board of Directors

Ref: GlobeNewswire

Tags: People News DBV Galderma Idorsia Novartis Corporate Affairs

Aptose Biosciences Establishes New At-The-Market Facility

Ref: GlobeNewswire

Tags: Press Release Aptose Biosciences Corporate Affairs

Heritage Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) as a result of a sterility test failure

Ref: PR Newswire

Tags: Press Release Emcure Pharmaceuticals Schizophrenia and Bipolar Disorder Bacterial Infections Marketing & Sales amikacin prochlorperazine

Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019

Ref: GlobeNewswire

Tags: Press Release Myovant Sciences Corporate Affairs relugolix

Medicines Australia welcomes Morrison Government Ministry

Ref: Medicines Australia

Tags: Press Release Australia Medicines Australia Corporate Affairs

BridgeBio Pharma Announces Filing of Registration Statement for Proposed Initial Public Offering

Ref: Business Wire

Tags: Press Release BridgeBio Pharma Corporate Affairs

Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA (pregabalin) in Primary Generalized Tonic-Clonic Seizures

Ref: Business Wire

Tags: Press Release Pfizer Epilepsy Clinical Research (R&D)Lyrica

Prophylaxis With Beta Blockers Reduces Atrial Fibrillation After Lung Transplantation

Tags: Conference Dispatch metoprolol